Combining Hepatic Arterial Interventional Therapies with Lenvatinib and Programmed Cell Death-1 Inhibitors for Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Single-Center, Real-World Study

Combining Hepatic Arterial Interventional Therapies with Lenvatinib and Programmed Cell Death-1 Inhibitors for Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Single-Center, Real-World Study

Xuehan Shen,* Tianyin Shao,* Jun Yu, Zhiwei Zhang Hepatic Surgery Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, People’s Republic of China*These authors contributed equally to this workCorrespondence...

Full description

Saved in:
Bibliographic Details
Main Authors: Shen X, Shao T, Yu J, Zhang Z
Format: Article
Language:English
Published: Dove Medical Press 2025-07-01
Series:Journal of Hepatocellular Carcinoma
Subjects:
hepatocellular carcinoma
hepatic arterial interventional therapies
lenvatinib
programmed cell death protein-1 inhibitors
portal vein tumor thrombosis
Online Access:https://www.dovepress.com/combining-hepatic-arterial-interventional-therapies-with-lenvatinib-an-peer-reviewed-fulltext-article-JHC
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.dovepress.com/combining-hepatic-arterial-interventional-therapies-with-lenvatinib-an-peer-reviewed-fulltext-article-JHC

Similar Items